Jump directly to

Jump directly to the main content
Jump directly to the search

Half-Year Financial Report 2026

Current language: English
Schakel taal over naar: Dutch

Switch language to: English
Schakel taal over naar: Dutch

Half-Year Financial Report 2026

Main menu

Management Report
Financial Statements
Auditor’s Report
- Auditor’s Report
- Report on the Review of Consolidated Interim Financial Information

Downloads Financial Calendar Glossary

Management Report
Downloads Financial Calendar Glossary
Financial Statements
Downloads Financial Calendar Glossary
Auditor’s Report
Downloads Financial Calendar Glossary
- Auditor’s Report
- Report on the Review of Consolidated Interim Financial Information

Home
Financial Statements
Notes
Approval of Interim Financial Statements

Approval of Interim Financial Statements

The interim financial statements were approved by the Board of Directors on August 5, 2026.

Downloads
Financial calendar
Glossary

previous page Events after the End of the Reporting Period

next page Statutory Auditor’s Report to the Board of Directors of Lakefront Biotherapeutics NV on the Review of Consolidated Interim Financial Information for the Six-Month Period Ended 30 June 2026

Other Information
Contact
Privacy Notice
Forward-Looking Statements

Downloads
Glossary

X
LinkedIn

2026 © Lakefront Biotherapeutics NV

Lakefront Biotherapeutics NV, Schaliënhoevedreef 20 T, 2800 Mechelen, Belgium